Saman supports Natl. plasma therapy program against COVID-19

May3, 2020
Saman Bank and Saman Insurance have started a cooperation with Iran’s plasma industry in order to fulfill their social responsibility in fight against the new coronavirus in Iran.
The cooperation has been established with Darman Ara company, a pioneer of Iran’s plasma industry, that has played a vital role in founding and developing plasma collecting centers in the country. Darman Ara earlier made a proposal to collect plasma from people who have recovered from COVID-19, launching an experimenting phase in a number of medical centers with 200 patients.
To help the project, Saman Insurance provided all researchers and sponsors of the plasma project with civil liability coverage. Saman Bank, on the other hand, covered 70 percent of insurance costs of the project to help its implementation.
Noteworthy, the plasma therapy method was already introduced by Chinese research centers. However, there is no precise report on the project’s success as China’s plasma industry is not as developed as it is in Iran. Meanwhile, the US Food and Drug Administration has recently approved the method as a treatment to the coronavirus infection and several US plasma centers are currently working on it.
Monday 4/19/2021